[Close]
- This page was created by volunteers like you!
- Help us make it even better. To learn more about contributing to MEpedia, click here.
- Join the movement
- Visit #MEAction to find support or take action. Donate today to help us improve and expand this project.
- Congratulations!
- MEpedia has got over 30 million views as of August 2022!
Leukotriene
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
 | This article is a stub. |
 | This article needs cleanup to meet MEpedia's guidelines. The reason given is: This page needs additional references or sources for verification - multiple references need to be added. (February 2021) |
Leukotrienes are a family of eicosanoids produced by the oxidation of arachidonic acid by the enzyme arachidonate 5-lipoxygenase (ALOX5).
Leukotriene production is usually accompanied by the production of histamine and prostaglandins. Leukotrienes are important in asthma.
Leukotriene inhibitors[edit | edit source]
Leukotriene inhibitors are a potential treatment for mast cell diseases including mast cell activation syndrome.
Leukotriene inhibitors include Montelukast (Singulair), Zafirlukast (Accolate) and Zileuton (Zyflo/Zyflo CR).[1]
Learn more[edit | edit source]
- Medications to Treat Mast Cell Diseases - The Mast Cell Disease Society
See also[edit | edit source]
References[edit | edit source]
- ↑ "Medications to Treat Mast Cell Diseases". The Mast Cell Disease Society. Retrieved February 16, 2021.
